Infectious Diseases

SCIENTIFIC INFORMATION

7:00am - 8:00am

EARLY BIRD SESSIONS

Lab of the Future: Cool Toys for the Diagnosis of Infectious Diseases

Validation of the Karius Microbial Cell-free DNA Sequencing Test for Infectious Disease
Timothy A. Blauwkamp, PhD, Karius, Inc., Redwood City, CA, USA

A Smart Diagnostic: Technology that Learned to Identify and Count Individual Bacteria in Blood
Stephanie I. Fraley, PhD, University of California, San Diego, CA, USA

1:00pm - 2:30pm

CONCURRENT WORKSHOPS

Role of Next Generation Sequencing for Outbreak Investigation

Viral Genomics in the Clinical Lab
Alex Greninger, MD, PhD, University of Washington, Seattle, WA, USA

NGS for Natural Disasters
Randall Olsen, MD, PhD, Houston Methodist Hospital and Research Institute, Houston, TX, USA

4:15pm - 5:45pm

PLENARY SESSION

 

SPECIAL SESSION: INFECTIOUS DISEASES

Meningitis/Encephalitis Syndromic Testing in the Clinical Setting: Is it Ready for Prime Time?

Are Meningitis/Encephalitis Panels Ready for Prime Time?
Kevin Alby, PhD, University of Pennsylvania, Philadelphia, PA, USA

Point-Counterpoint: Molecular Diagnosis of Meningitis/Encephalitis
Jennifer Dien Bard, PhD
Children's Hospital Los Angeles, Los Angeles, CA, USA
University of Southern California, Los Angeles, CA, USA

 

Friday, November 2, 2018

SCIENTIFIC INFORMATION

7:00am - 8:00am

EARLY BIRD SESSIONS

Keys to Publishing in Scientific Journals

Barbara A. Zehnbauer, PhD, Emory University School of Medicine, Atlanta, GA, USA

8:15am - 9:15am

SPECIAL SESSION: INFECTIOUS DISEASES

The Role of Genomic Susceptibility Testing in Predicting Antimicrobial Responses

Use of Molecular Testing to Predict Gonorrhea Treatment
Jeffrey D. Klausner, MD, MPH, University of California, Los Angeles, CA, USA

Value of Molecular AST Methods for Bacteria: Are We There?
Romney M. Humphries, PhD, Accelerate Diagnostics, Tucson, AZ, USA

10:45am - 11:45am

CONCURRENT WORKSHOPS:

Platform Presentations of Selected Abstracts

Abstracts are selected by the Program Committee

Platform Presentations of Selected Infectious Diseases Abstracts

ID004 - Evaluation of a Novel Isothermal Amplification Assay for Detection and Genotyping of Human Papillomavirus in Formalin-fixed Paraffin-embedded Tissue of Oropharyngeal Carcinomas
Yi-Wei Tang, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, USA

ID012 - Comprehensive Solid Tumor Microbiome Profiling via Analysis of Unmapped Reads in Large Panel, Hybridization Capture-based NGS Assay Data
Chad M. Vanderbilt, MD, Memorial Sloan Kettering Cancer Center, New York, NY, USA

ID063 - A Quantitative, Multiplexed RNA Detection Platform for Rapid Pathogen Identification and Phenotypic Antibiotic Susceptibility Testing (AST) using NanoString(™) Technology
Roby P. Bhattacharyya, MD, PhD, Broad Institute, Cambridge, MA, USA
Massachusetts General Hospital, Boston, MA, USA

ID007 - The Diagnostic Yield of Universal Pathogen Detection by Next-Generation Sequencing Compared to the Standard of Care in Patients with Pneumonia
Brittany A. Young, MD, PhD, University of Utah, Salt Lake City, UT, USA

12:15pm - 1:00pm

SPECIAL SESSION: INFECTIOUS DISEASES

ID Town Hall Meeting

1:00pm - 2:30pm

PLENARY SESSION

Microbiome and Predictive Response to Immunotherapy

Microbiome Changes with Infectious Complications During Stem Cell Transplantation
Ying Taur, MD, MPH, Memorial Sloan Kettering Cancer Center, New York, NY, USA

The Intestinal Virome: From Chronic Inflammation to Bacteriophage Therapy Targeting Multidrug Resistant Bacteria
Breck A. Duerkop, PhD, University of Colorado School of Medicine, Aurora, CO, USA

3:30pm - 5:00pm

CONCURRENT SYMPOSIA

Utilization of CRISPR/Cas Technique as Anti-Viral Therapeutic Agent and as an Adaptive Immune Modulator in DNA Editing and RNA Targeting

CRISPR/Cas9 Targeting and Inactivation of Viral DNA Genomes
Bryan R. Cullen, PhD, Duke University Medical Center, Durham, NC, USA

Programmable RNA-targeting CRISPR-Cas Enzymes for RNA Detection and Therapeutics
Mitchell R. O'Connell, PhD, University of Rochester, Rochester, NY, USA

 

 

 

 

Saturday, November 3, 2018

SCIENTIFIC INFORMATION

8:15am - 9:15am

SPECIAL SESSION: INFECTIOUS DISEASES & MOLECULAR ONCOLOGY

Test Utilization and Clinical Utility of Molecular Test

Opportunities and Challenges in Laboratory Stewardship: Leaders Apply Here
Gary Procop, MD, Cleveland Clinic, Cleveland, OH, USA

10:45am - 12:15pm

WORKSHOPS

Enterovirus D68 and Acute Flaccid Myelitis: What We've Learned Since 2014

The Role of Enterovirus D68 in Acute Flaccid Myelitis
Kevin Messacar, MD, University of Colorado/Children's Hospital Colorado, Aurora, CO, USA

Epidemiology, Surveillance, and Diagnosis of Enterovirus D68
Samuel Dominguez, MD, PhD, University of Colorado/Children's Hospital Colorado, Aurora, CO, USA

1:30pm - 3:00pm

CONCURRENT SYMPOSIA

Metagenomic Characterization of Molecular Scientists

Christopher E. Mason, PhD, Weill Cornell Medicine, New York, NY, USA